» Articles » PMID: 24393790

Rapid Antibiotic Susceptibility Phenotypic Characterization of Staphylococcus Aureus Using Automated Microscopy of Small Numbers of Cells

Overview
Specialty Microbiology
Date 2014 Jan 8
PMID 24393790
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Staphylococcus aureus remains a leading, virulent pathogen capable of expressing complex drug resistance that requires up to 2-4 days for laboratory analysis. In this study, we evaluate the ability of automated microscopy of immobilized live bacterial cells to differentiate susceptible from non-susceptible responses of S. aureus isolates (MRSA/MSSA, clindamycin resistance/susceptibility and VSSA/hVISA/VISA) to an antibiotic based on the characterization of as few as 10 growing clones after 4 h of growth, compared to overnight growth required for traditional culture based methods. Isolates included 131 characterized CDC isolates, 3 clinical isolates and reference strains. MRSA phenotype testing used 1 h of 1 μg/mL cefoxitin induction followed by 3 h of 6 μg/mL cefoxitin. Clindamycin susceptibility testing used 1h of induction by 0.1 μg/mL erythromycin followed by 3h of 0.5 μg/mL clindamycin. An automated microscopy system acquired time-lapse dark-field images, and then computed growth data for individual immobilized progenitor cells and their progeny clones while exposed to different test conditions. Results were compared to concurrent cefoxitin disk diffusion and D-test references. For CDC organisms, microscopy detected 77/77 MRSA phenotypes and 54/54 MSSA phenotypes, plus 53/56 clindamycin-resistant and 75/75 clindamycin susceptible strains. Automated microscopy was used to characterize heterogeneous and inducible resistance, and perform population analysis profiles. Microscopy-based hVISA population analysis profiles (PAPs) were included as an extended proof of concept, and successfully differentiated VSSA from hVISA and VISA phenotypes compared to plate-based PAP.

Citing Articles

Next-generation rapid phenotypic antimicrobial susceptibility testing.

Reszetnik G, Hammond K, Mahshid S, AbdElFatah T, Nguyen D, Corsini R Nat Commun. 2024; 15(1):9719.

PMID: 39521792 PMC: 11550857. DOI: 10.1038/s41467-024-53930-x.


A preliminary investigation into bacterial viability using scanning electron microscopy-energy-dispersive X-ray analysis: The case of antibiotics.

Haddad G, Takakura T, Bellali S, Fontanini A, Ominami Y, Bou Khalil J Front Microbiol. 2022; 13:967904.

PMID: 36003945 PMC: 9393632. DOI: 10.3389/fmicb.2022.967904.


A Polymer-Based Multichannel Sensor for Rapid Cell-Based Screening of Antibiotic Mechanisms and Resistance Development.

Basu Roy S, Nabawy A, Chattopadhyay A, Geng Y, Makabenta J, Gupta A ACS Appl Mater Interfaces. 2022; .

PMID: 35638721 PMC: 10587897. DOI: 10.1021/acsami.2c07012.


Metabolic preference assay for rapid diagnosis of bloodstream infections.

Rydzak T, Groves R, Zhang R, Aburashed R, Pushpker R, Mapar M Nat Commun. 2022; 13(1):2332.

PMID: 35484129 PMC: 9050716. DOI: 10.1038/s41467-022-30048-6.


Rapid Determination of Antibiotic Resistance in by a Novel Antibiotic Susceptibility Testing Method Using SYBR Green I and Propidium Iodide Double Staining.

Zhang Y, Fan W, Shao C, Wang J, Jin Y, Shao J Front Microbiol. 2021; 12:650458.

PMID: 34177832 PMC: 8221289. DOI: 10.3389/fmicb.2021.650458.